Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilar Cost Savings in the United States: Initial Experience and Future Potential
Biosimilar Cost Savings in the United States: Initial Experience and Future Potential
2017
Andrew W. Mulcahy
Jakub P Hlávka
Spencer R. Case
Keywords:
Business
Health economics
Public economics
Biosimilar
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]